Correlation Between GM and Sarepta Therapeutics
Can any of the company-specific risk be diversified away by investing in both GM and Sarepta Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GM and Sarepta Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between General Motors and Sarepta Therapeutics, you can compare the effects of market volatilities on GM and Sarepta Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GM with a short position of Sarepta Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of GM and Sarepta Therapeutics.
Diversification Opportunities for GM and Sarepta Therapeutics
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between GM and Sarepta is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding General Motors and Sarepta Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sarepta Therapeutics and GM is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on General Motors are associated (or correlated) with Sarepta Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sarepta Therapeutics has no effect on the direction of GM i.e., GM and Sarepta Therapeutics go up and down completely randomly.
Pair Corralation between GM and Sarepta Therapeutics
Allowing for the 90-day total investment horizon General Motors is expected to generate 0.69 times more return on investment than Sarepta Therapeutics. However, General Motors is 1.46 times less risky than Sarepta Therapeutics. It trades about 0.13 of its potential returns per unit of risk. Sarepta Therapeutics is currently generating about 0.08 per unit of risk. If you would invest 5,154 in General Motors on August 30, 2024 and sell it today you would earn a total of 396.00 from holding General Motors or generate 7.68% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
General Motors vs. Sarepta Therapeutics
Performance |
| Timeline |
| General Motors |
| Sarepta Therapeutics |
GM and Sarepta Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GM and Sarepta Therapeutics
The main advantage of trading using opposite GM and Sarepta Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GM position performs unexpectedly, Sarepta Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sarepta Therapeutics will offset losses from the drop in Sarepta Therapeutics' long position.The idea behind General Motors and Sarepta Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Sarepta Therapeutics vs. Krystal Biotech | Sarepta Therapeutics vs. PTC Therapeutics | Sarepta Therapeutics vs. Iovance Biotherapeutics | Sarepta Therapeutics vs. Madrigal Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |